LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP5 | 1.0182 | 0.0218 | 1.0242 | 0.0291 |
| MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP6 | 0.9703 | 0.0319 | 0.9589 | 0.0436 |
| MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 0.8662 | 0.0152 | 0.8191 | 0.0192 |
| MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 0.4115 | 0.0376 | 0.2020 | 0.0583 |
| MDA-MB-231 | GSK 690693 | 0.12 | uM | LJP5 | 0.9169 | 0.0224 | 0.8880 | 0.0292 |
| MDA-MB-231 | GW843682X | 0.12 | uM | LJP6 | 0.7591 | 0.0497 | 0.6733 | 0.0688 |
| MDA-MB-231 | HG-5-113-01 | 0.12 | uM | LJP5 | 0.9017 | 0.0505 | 0.8682 | 0.0671 |
| MDA-MB-231 | HG-5-88-01 | 0.12 | uM | LJP6 | 0.8625 | 0.0555 | 0.8151 | 0.0732 |
| MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 0.9940 | 0.0318 | 0.9911 | 0.0428 |
| MDA-MB-231 | JNK-9L | 0.12 | uM | LJP6 | 0.7491 | 0.0218 | 0.6607 | 0.0263 |
| MDA-MB-231 | JW-7-24-1 | 0.12 | uM | LJP6 | 0.8608 | 0.0391 | 0.8125 | 0.0509 |
| MDA-MB-231 | Lapatinib | 0.12 | uM | LJP6 | 0.9355 | 0.0110 | 0.9124 | 0.0158 |
| MDA-MB-231 | LDN-193189 | 0.12 | uM | LJP5 | 0.9481 | 0.0316 | 0.9290 | 0.0429 |
| MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 1.0796 | 0.0342 | 1.1071 | 0.0451 |
| MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 0.8617 | 0.0418 | 0.8133 | 0.0553 |
| MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP5 | 0.2392 | 0.0155 | -0.0308 | 0.0310 |
| MDA-MB-231 | Mitoxantrone | 0.12 | uM | LJP6 | 0.2234 | 0.0152 | -0.0522 | 0.0303 |
| MDA-MB-231 | MK2206 | 0.12 | uM | LJP6 | 0.9022 | 0.0158 | 0.8675 | 0.0215 |
| MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 0.8875 | 0.0928 | 0.8499 | 0.1235 |
| MDA-MB-231 | Nilotinib | 0.12 | uM | LJP5 | 0.9293 | 0.0658 | 0.9057 | 0.0876 |
| MDA-MB-231 | Nintedanib | 0.12 | uM | LJP6 | 1.0333 | 0.0060 | 1.0450 | 0.0078 |
| MDA-MB-231 | NU7441 | 0.12 | uM | LJP5 | 0.9630 | 0.0319 | 0.9506 | 0.0432 |
| MDA-MB-231 | Dactolisib | 0.12 | uM | LJP5 | 0.4415 | 0.0590 | 0.2421 | 0.0874 |
| MDA-MB-231 | NVP-TAE684 | 0.12 | uM | LJP6 | 0.7558 | 0.0476 | 0.6702 | 0.0615 |
| MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 0.6321 | 0.0316 | 0.5010 | 0.0476 |